Biogen, Inc. (BIIB)
Biogen Market Cap: 24.12B for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Eli Lilly & Co. | 929.39B |
| AbbVie, Inc. | 378.84B |
| Stoke Therapeutics, Inc. | 1.639B |
| Alnylam Pharmaceuticals, Inc. | 47.46B |
| Insmed, Inc. | 34.43B |
Market Cap Related Metrics
| PE Ratio | 14.99 |
| PS Ratio | 2.488 |
| Price to Book Value | 1.325 |
| Price to Free Cash Flow | 10.66 |
| Price | 164.42 |
| Earnings Yield | 6.67% |
| Operating PE Ratio | 9.884 |
| Normalized PE Ratio | 13.29 |